Skip to main content
Category

Press

Press

CRO Growth Continues, ISR Projects More Growth to Come

Informing the drug development and pharmaceutical manufacturing industry. Raleigh, N.C. – September 25, 2018 – Industry Standard Research (ISR) has announced the newest edition of its CRO market analysis report “2018 CRO Market Size Projections: 2017-2022.” For this report, ISR has…
Tyler
September 25, 2018
Press

Large CROs Stand Out in Post-marketing Pharmacovigilance

Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – September 24, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its CRO Quality Benchmarking – Phase IV Service Providers series. ISR surveyed 230 decision-makers at sponsor…
Tyler
September 24, 2018
Press

Accenture and Medpace Excel in Phase II/III Delivery Factors

The 10th Edition of ISR's Phase II/III CRO Benchmarking has arrived Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – May 17, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its…
Tyler
May 17, 2018
Press

ISR Projects Strong Growth in the CRO Market

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 7, 2017 – Industry Standard Research (ISR) today announced the release of its latest CRO market report titled; 2017 Edition of the CRO Market Size Projections: 2016-2021.…
Stephen Baker
March 10, 2017
Press

ISR Projects the 2014 CRO Market to be Worth $23.6 Billion

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 4, 2014 – Industry Standard Research (ISR) has announced the availability of a new report titled “2014 CRO Market Size Projections: 2012-2018.”  For this report, ISR has utilized…
Jeremy Klein
February 4, 2014
Press

ISR Expands Biosimilar Library with Two New Reports

Informing the Drug Development and Commercialization Industry Cary, N.C. - January 31, 2012 - Industry Standard Research (ISR) today announced the release of two new reports focused on the biosimilar industry. “US Payers and Biosimilar Formulary Placement” and “Biosimilars: A…
Jeremy Klein
January 31, 2012